Picture of GoodRx Holdings logo

GDRX — GoodRx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapSuper Stock

GoodRx Holdings Inc expected to post earnings of 8 cents a share - Earnings Preview

GoodRx Holdings Inc <GDRX.OQ> expected to post earnings of 8 cents a share - Earnings Preview 
  • GoodRx Holdings Inc GDRX.OQ GDRX.O is expected to show a fall in quarterly revenue when it reports results on August 5 for the period ending June 30 2026

  • The Santa Monica California-based company is expected to report a 4.9% decrease in revenue to $193.162 million from $203.07 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data. (SAL is based on Total Revenue Basis)

  • ​LSEG's mean analyst estimate for GoodRx Holdings Inc is for earnings of 8 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 8 "hold" and 2 "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 1.2% in the last three months. ​

  • Wall Street's median 12-month price target for GoodRx Holdings Inc is $3.00, about 2.3% below its last closing price of $3.07

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2026

0.07

0.07

0.07

Met

-2.8

Dec. 31 2026

0.09

0.09

0.09

Met

-1.7

Sep. 30 2025

0.09

0.09

0.08

Missed

-11.7​

Jun. 30 2025

0.10

0.10

0.09

Missed

-8.9

​​Mar. 31 2025

0.10

0.10

0.09

Missed

-5.3

Dec. 31 2024

0.09

0.10

0.09

Missed

-6.8​

Sep. 30 2024

0.08

0.09

0.08

Missed

-7.2

Jun. 30 2024

0.08

0.09

0.08

Missed

-8.4

This summary was machine generated August 3 at 21:03 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on GoodRx Holdings

See all news